FDA: Data suggests Abbott’s rapid coronavirus diagnostic test is delivering inaccurate results

- Advertisement -
KEY POINTS
  • The U.S. Food and Drug Administration issued an alert on Thursday saying there is early data that suggests  Abbott Labs’ rapid coronavirus diagnostic test for Covid-19 may be delivering inaccurate results.
  • Specifically, the Abbott ID NOW test may return false negative results, the FDA said.
- Advertisement -
- Advertisement -
- Advertisement -
A box containing a 5-minute test for COVID-19 from Abbott Laboratories is pictured during the daily briefing on the novel coronavirus, COVID-19, in the Rose Garden of the White House in Washington, DC, on March 30, 2020.
A box containing a 5-minute test for COVID-19 from Abbott Laboratories is pictured during the daily briefing on the novel coronavirus, COVID-19, in the Rose Garden of the White House in Washington, DC, on March 30, 2020.
Mandel Ngan | AFP | Getty Images

The U.S. Food and Drug Administration issued an alert on Thursday saying there is early data that suggests  Abbott Labs’ rapid Covid-19 diagnostic test for may be delivering inaccurate results.

Specifically, the Abbott ID NOW test may return false negative results, the FDA said.

“We are still evaluating the information about inaccurate results and are in direct communications with Abbott about this important issue,” said Tim Stenzel, director of the Office of In Vitro Diagnostics and Radiological Health at the FDA’s Center for Devices and Radiological Health, in a statement. “We will continue to study the data available and are working with the company to create additional mechanisms for studying the test.”

Despite these concerns, ID NOW may continue to be used to correctly identify positive cases, but negative results may need confirmation from a high-sensitivity authorized molecular test Stenzel said.

Abbott’s share price dropped following the FDA alert, and it is down more than 3% in after-hours trading.

The FDA alert comes a day after researchers at New York University published a study claiming the ID NOW test missed a third of samples collected with nasopharyngeal swabs that tested positive with a test from rival Cepheid.

Abbott Labs refuted the NYU study’s claims that its rapid coronavirus diagnostic test could be missing nearly half of positive cases.

“While we understand no test is perfect, test outcomes depend on a number of factors including patient selection, specimen type, collection, handling, storage, transport and conformity to the way the test was designed to be run,” Abbott said in a statement on Thursday. “ID NOW is intended to be used near the patient with a direct swab test method.”

Home of Science
Follow me

Latest posts by Home of Science (see all)
- Advertisement -

Discover

Sponsor

Latest

Improve Your Streaming Experience With Netflix

As the greatest online video streaming service in the world, Netflix has been growing rapidly. The service has almost caught up with the likes...

Should You Go to the Recession Warning on Oprah?

Should You Go to the Recession Warning on Oprah?Oprah has been known to have a bit of an agenda when it comes to...

Climate gentrification: How extreme weather is displacing low-income residents from their communities

Sea levels are rising at an alarming rate — and for Miami-Dade County, situated between 4 and 6 feet above sea level and with a...

CaSSIS mission: The camera capturing Mars’ craters and canyonson February 13, 2021 at 1:46 am

The instrument takes images of dust storms, frost deposits and minerals on the Red Planet's surface.image copyrightESA/Roscosmos/CaSSISIt is a busy time for Mars at...

Oprah Is Running Her Own Network

Oprah Winfrey has been one of the most successful and well known personalities in television for many years. In fact, for several years she...
Home of Science
Follow me
Latest posts by Home of Science (see all)